Off-Label Reprint Distribution Outside Of FDAMA Is Legal, FDA Tells Court
This article was originally published in The Gray Sheet
Executive Summary
Off-label promotions are considered illegal by FDA only if they expressly violate an agreement struck between FDA and industry under FDA Modernization Act provisions, FDA attorneys told a three-judge panel of the Washington, D.C. appellate court reviewing Washington Legal Foundation v. Henney.